RET genotypes in sporadic medullary thyroid cancer: Studies in a large Italian series

Laura Fugazzola, Marina Muzza, Caterina Mian, Daniela Cordella, Susi Barollo, Luisella Alberti, Valentina Cirello, Davide Dazzi, Maria Elisa Girelli, Giuseppe Opocher, Paolo Beck-Peccoz, Luca Persani

Research output: Contribution to journalArticle

Abstract

Background: Highly discrepant data about the different distribution of RET germline single nucleotide polymorphisms (SNPs) among patients with sporadic medullary thyroid cancer (sMTC) and controls are available. Design and patients: In the present case-control study, a wide panel of seven RET SNPs has been tested in the largest sMTC series and in a matched control group. Results: None of the investigated polymorphisms show a significantly different distribution in patients with sMTC when compared to controls. Twenty haplotypes and 57 genotypes were generated, and their association with the disease and with the clinical features were statistically evaluated. Interestingly, 14 genotypes were found to be unique to sMTC patients and 25 to controls. Two haplotypes and three genotypes, all including the intronic variants IVS1-126 and IVS14-24, were significantly associated with sMTC patients and with a higher tumour aggression. The functional activity of the only nonsynonymous RET variant (c.2071C > A, G691S) was tested for the first time. Interestingly, Western blot analyses showed that the fraction of Ret9-G691S protein located at the plasma membrane level was overrepresented when compared to Ret9-WT, suggesting facilitated targeting at the cell membrane for this variant. However, no transforming activity was shown in a focus formation assay on cells carrying the Ret9-G691S, against a possible oncogenic role of G691S variant. Conclusions: RET genotypes including two intronic RET variants were associated with the risk of developing sMTC and to more aggressive behaviour. Further studies are warranted to elucidate whether these RET genotypes are in linkage disequilibrium with another susceptibility gene or whether these variants could play a role in the genesis of sMTC per se.

Original languageEnglish
Pages (from-to)418-425
Number of pages8
JournalClinical Endocrinology
Volume69
Issue number3
DOIs
Publication statusPublished - Sep 2008

ASJC Scopus subject areas

  • Endocrinology

Fingerprint Dive into the research topics of 'RET genotypes in sporadic medullary thyroid cancer: Studies in a large Italian series'. Together they form a unique fingerprint.

  • Cite this

    Fugazzola, L., Muzza, M., Mian, C., Cordella, D., Barollo, S., Alberti, L., Cirello, V., Dazzi, D., Girelli, M. E., Opocher, G., Beck-Peccoz, P., & Persani, L. (2008). RET genotypes in sporadic medullary thyroid cancer: Studies in a large Italian series. Clinical Endocrinology, 69(3), 418-425. https://doi.org/10.1111/j.1365-2265.2008.03218.x